SP-MHCI-0929-2

SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA

US$169.00

In stock

Description

About SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA

The SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) ORF Protein 8 Peptide (IEDB: 1310428) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The ORF Protein Peptide, H-FYSKWYIRVGARKSA-OH (Uniprot: P0DTC8 aa: 41-55) from JPT is produced under strict quality control and quality management.

SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA - Specifications

  • Peptide sequence: H-FYSKWYIRVGARKSA-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Covid-19
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA

References:
Read References with JPT’s Antigen Peptides
SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA has been described in:
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans., Science, 2020 (PMID: 32753554)
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases., Cell Rep Med, 2021 (PMID: 33521695)

Documentation

Documentation for SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA

Properties

Properties of SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Covid-19
Layout: Freeze-dried in glass vial
Organism: SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Protein Name: ORF Protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA

Information Values
Sequence: H-FYSKWYIRVGARKSA-OH
Specifications: 15mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote